Lu Yu

机构：Harbin Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Medical Products Administration, Southwest Medical University, Third Affiliated Hospital of Harbin Medical University, Fu Wai Hospital, University of Maryland, College Park · ORCID：0000-0001-7901-8390

发表论文 57 篇 · 总被引 1687 次 · h-index 23

代表论文

• Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8 (2019 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 被引 60)
• The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review (2021 · Diabetes Metabolic Syndrome and Obesity · 被引 48)
• Inhibition of Tumor Growth by Dietary Indole-3-Carbinol in a Prostate Cancer Xenograft Model May Be Associated with Disrupted Gut Microbial Interactions (2019 · Nutrients · 被引 43)
• Diosgenin alleviates hypercholesterolemia via SRB1/CES-1/CYP7A1/FXR pathway in high-fat diet-fed rats (2020 · Toxicology and Applied Pharmacology · 被引 39)
• Chemical profile and in vitro gut microbiota modulatory, anti-inflammatory and free radical scavenging properties of chrysanthemum morifolium cv. Fubaiju (2019 · Journal of Functional Foods · 被引 32)
• Quantitative synthetic MRI for evaluation of the lumbar intervertebral disk degeneration in patients with chronic low back pain (2020 · European Journal of Radiology · 被引 30)